Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP810785.RARi3COfm7bWs-axhB1CCoPxURzTTg-ocr12aCdf8omMA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP810785.RARi3COfm7bWs-axhB1CCoPxURzTTg-ocr12aCdf8omMA130_assertion type Assertion NP810785.RARi3COfm7bWs-axhB1CCoPxURzTTg-ocr12aCdf8omMA130_head.
- NP810785.RARi3COfm7bWs-axhB1CCoPxURzTTg-ocr12aCdf8omMA130_assertion description "[We used a large panel of breast cancer cell lines and in vivo xenograft models to identify candidate predictive biomarkers for a selective inhibitor of class I PI3K that is currently in clinical development.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP810785.RARi3COfm7bWs-axhB1CCoPxURzTTg-ocr12aCdf8omMA130_provenance.
- NP810785.RARi3COfm7bWs-axhB1CCoPxURzTTg-ocr12aCdf8omMA130_assertion evidence source_evidence_literature NP810785.RARi3COfm7bWs-axhB1CCoPxURzTTg-ocr12aCdf8omMA130_provenance.
- NP810785.RARi3COfm7bWs-axhB1CCoPxURzTTg-ocr12aCdf8omMA130_assertion SIO_000772 20453058 NP810785.RARi3COfm7bWs-axhB1CCoPxURzTTg-ocr12aCdf8omMA130_provenance.
- NP810785.RARi3COfm7bWs-axhB1CCoPxURzTTg-ocr12aCdf8omMA130_assertion wasDerivedFrom befree-2016 NP810785.RARi3COfm7bWs-axhB1CCoPxURzTTg-ocr12aCdf8omMA130_provenance.
- NP810785.RARi3COfm7bWs-axhB1CCoPxURzTTg-ocr12aCdf8omMA130_assertion wasGeneratedBy ECO_0000203 NP810785.RARi3COfm7bWs-axhB1CCoPxURzTTg-ocr12aCdf8omMA130_provenance.